Taysha Gene Therapies Executive Sells Over $1.6 Million in Company Stock
Reporter NameNagendran SukumarRelationshipPresident and Head of R&D, 10% OwnerTypeSellAmount$1,695,905SEC FilingForm 4Nagendran Sukumar, President and Head of R&D at Taysha Gene Therapies and a 10% owner, sold 370,172 shares of common stock across two transactions on November 28 and December 1, 2025, for a total of $1,695,905. The sales were made at weighted average prices of $4.75 and $4.51 per share, respectively. Following these transactions, Sukumar directly owns 1,006,439 shares of Taysha Gene Therapies.SEC Filing: Taysha Gene Therapies, Inc. [ TSHA ] - Form 4 - Dec. 01, 2025
| Reporter Name | Nagendran Sukumar |
| Relationship | President and Head of R&D, 10% Owner |
| Type | Sell |
| Amount | $1,695,905 |
| SEC Filing | Form 4 |
Nagendran Sukumar, President and Head of R&D at Taysha Gene Therapies and a 10% owner, sold 370,172 shares of common stock across two transactions on November 28 and December 1, 2025, for a total of $1,695,905. The sales were made at weighted average prices of $4.75 and $4.51 per share, respectively. Following these transactions, Sukumar directly owns 1,006,439 shares of Taysha Gene Therapies.
SEC Filing: Taysha Gene Therapies, Inc. [ TSHA ] - Form 4 - Dec. 01, 2025
